Fibroblast Growth Factor 23 and Osteoporosis: Evidence from Bench to Bedside

Fibroblast Growth Factor 23 and Osteoporosis: Evidence from Bench to Bedside

Osteoporosis is a chronic debilitating disease caused by imbalanced bone remodeling processes that impair the structural integrity of bone. Over the last ten years, the association between fibroblast growth factor 23 (FGF23) and osteoporosis has been studied in both pre-clinical and clinical investi...

Full description

Bibliographic Details
Main Authors: Wachiranun Sirikul, Natthaphat Siri-Angkul, Nipon Chattipakorn, Siriporn C. Chattipakorn
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:International Journal of Molecular Sciences
Subjects:
FGF23
osteoblast
osteoclast
biochemical markers
bone remodeling
osteoporosis
Online Access:https://www.mdpi.com/1422-0067/23/5/2500

Internet

https://www.mdpi.com/1422-0067/23/5/2500

Similar Items